Saifu Pharmaceutical announced the appointment of Dr. Dai Xuedong as the Vice President of Saifu Pharmaceutical Group, mainly responsible for the non-clinical evaluation and research related work of cooperative customer projects. It is reported that Dr. Dai Xuedong has been focusing on the research and evaluation of the pharmacology and toxicology of new drugs. Before joining Saifu Medicine, he worked in the Center for Drug Evaluation (CDE) of the State Drug Administration for many years as the chief reviewer, mainly responsible for Professional review of new drug pharmacology and toxicology. Dr. Dai Xuedong has completed nearly 1,000 types of pharmacology and toxicology professional evaluations during his work in the Center for Drug Evaluation. He has extensive review experience.
This article is reproduced from: https://mp.weixin.qq.com/s/TNE-J1wtKZQyrEyUHykgaQ
This site is for inclusion only, and the copyright belongs to the original author.